ClinicalTrials.gg
Sign In

Ribocure Pharmaceuticals AB clinical trials

A subsidiary of Suzhou Ribo Life Science Co., Ltd.

The registry lists 6 studies whose lead sponsor is Ribocure Pharmaceuticals AB. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.

What it is testing

The drugs Ribocure Pharmaceuticals AB’s studies test, most open studies first — 4 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Ribocure Pharmaceuticals AB’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. 1J
  10. A
  11. 1S
  12. O
  13. N

All 3

Add all 3 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 16, 2026.

Newly registered1

All 6 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now467%Not yet recruiting 3 · Recruiting 1
  • Under way, not recruiting117%
  • Completed117%

Phase

  • Phase 26

Where

  • Sweden5
  • Poland3
  • Romania1
  • Denmark1
  • France1
  • Bulgaria1

Over the years

  1. 24
  2. 25
  3. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Ribocure Pharmaceuticals AB6 studies

Something wrong with this grouping? Tell us on the Suzhou Ribo Life Science Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 6 of 6. All Suzhou Ribo Life Science Co., Ltd. studies →